Not a lot of buying and selling going on this week, as the market continues to seem to be reacting only to the “thumbs up” or “thumbs down” sentiment over a possible Chinese trade deal, but I did find one stock to buy… and caught up on a few others that have been catching my […]
Articles
- Most Relevant
- Most Recent
I just realized that we blew through the 11-year anniversary of the launch of Stock Gumshoe just a few days ago… and forgot to have a party or light the fireworks or anything. Ooops. Guess I was distracted by this nutty stock market… so, “happy birthday to us!” And thank you, dearest Irregular, for making […]
Chris Mayer runs the Capital and Crisis newsletter, often looking for far-flung stocks or odd special situations, and he sometimes brings an interesting idea or two to us through his teaser pitches … so I thought we’d take a look at his latest idea today, a spiel about some stocks that you can buy and […]
On-Location and online courses in stock trading, forex, futures, options and wealth management.
In how many areas of life can you be guaranteed to get average results even if your abilities are inferior? That was one of my favorites quotes from the presentation by Ed Wachenheim at the Grant’s Conference: “People with inferior abilities can get average results with an index fund, which is remarkable.” But, of course, […]
For those who’ve been paying attention, we finally got the expected official Dataram/US Gold name/ticker change…. it’s now U.S. Gold Corp, an the ticker is now USAU. The stock is not moving at the moment, which makes sense — I’d guess that the highest probability near-term news is a secondary offering, which would be negative… […]
The ides of February are dismal and dreary here in the wet and grey Pioneer Valley of Massachusetts, but we remain hopeful of the sunshine to come. What do I have to share with you, dear Irregulars, as we seek a little brightness to end the week? Well, I do have a few buys to […]
Welcome to another Friday of earthly delights! We’ve had some new folks join our numbers in the past few months, so I thought I’d catch you up on the Real Money Portfolio and what it represents… and why I write about it for you. After that, I’ll catch you up on my thinking on a […]
Well, it’s the beginning of a new year and time for introspection — so I thought I’d revisit some of the older ideas I’ve profiled for the Idea of the Month, and list all of the Ideas in my order of preference today. So first, the list — if I were buying today from the […]
This article originally appeared on January 28, 2015, when the ad was newly released — the same ad, without any major revisions that we noticed, is being distributed widely again and generating questions, so we make this piece available again. The stock teased is at roughly the same price now as it was on January […]
Newsletters are notorious for re-using the same ad copy for years and years and years, and the Motley Fool is no different — when they get a marketing pitch that really works, they keep trotting it out again, and again, and again. I’ve mentioned this before, particularly with their “Next Berkshire Hathaway” pick that gets […]
I haven’t written about Yiannis Mostrous in a while, but his latest ad that teases a hot investment that he calls “The Next McDonald’s” definitely got my attention. It’s a big promise, after all: “Thousands of investors became millionaires and lived their dreams as 100 shares of McDonald’s split 12 times and turned into a […]
Yes, that’s not my headline — I borrowed it from the ad I was asked to look at, the “special presentation for fast-moving readers” from Agora Financial’s Microcap Millionaires. The other possible headline would have been, also from the ad, “This Tiny Company Could Be The Next Household-Name Mega-Brand.” So you see, that’s not much […]
Usually when you hear “little-known Canadian stock” you think, “hey, that’s probably some miner lying about their assay samples out of a storefront office in Vancouver” … but this one’s a little different. To start with, it’s not a mining stock, and has nothing to do with gold or tar sands or pipelines or any […]
Ian Wyatt is selling his High-Yield Wealth newsletter by promising to help you get your first “gas rebate check” that can offset your high fuel expenses. Which sounds appealing, right? No one likes to fill up at the gas station, and people go gaga even for simple store card rebate programs that give you five […]
We continue to see worrisome commentary about market valuations, with hand-wringing about whether the stock market is overvalued or might be in a bubble… and it can get a bit draining, frankly. Caution is important, diversification is important, but worrying does us little good. Yes, investors are paying a steep price for anticipated growth in […]
This one was recently forwarded by a reader, with a tip as to the company he thought it was (he was right, too). And this is actually a company I owned a few years ago around their IPO, so this is also a nice bitter reminder that I shouldn’t have sold it. The ad is […]
“When this controversial law takes effect on October 1, 2011… folks who act now could get ‘hedge fund rich’” That’s how Zachary Scheidt is launching his new service, called Hedge Fund Strategist from Taipan, a publisher in the Baltimore Agora-plex (Taipan is currently in the process of renaming itself “Insiders Strategy Group,” just to keep […]
Ah, another one from the Motley Fool! Like mother’s milk, it nourishes the Gumshoe so to pore through a ponderous Fool tome in search of clues to great stocks. Today, we’re blessed with a teaser letter for the Hidden Gems newsletter, with the letter coming from Bill Mann, who runs that newsletter in partnership with […]
I’ll warn you up front: if you’ve been sailing the seas with us here on the good ship Gumshoe for more than a couple years, you’ve already seen this one. But Benjamin Shepherd at the Global Investment Strategist is now saying that it’s “The One Stock You Must Buy in 2014” so I thought we […]
This is the third time I’ve bought an IPO on its first day of trading, and the second time I’ve bought exposure to a SPAC over the past year — hopefully it will work out as well as the others. I saw Chamath Palihapitiya speak at the Delivering Alpha conference on Tuesday, along with Starwood’s […]
Weekly escalations in nuclear threats, record-breaking hurricanes… what is it going to take to shake investor sentiment for more than 24 hours? The S&P 500 is ending the week only down about a third of one percent, gold is up less than 2%, this is a market that is reacting to headlines pretty quickly… but […]
Glenn Newberry in an earlier post today was asking whether Benlysta from GlaxoSmithKline (GSK), being trialled for lupus nephritis, poses any threat to Aurinia (AUPH). Benlysta is a monoclonal antibody that binds to and inhibits BAFF (B-cell activating factor). A company called Anthera (ANTH) is trialling blisibimod, an oral agent that does the same thing. […]
Fridays are the day I write for you, my dear Irregular friend, so this time you’re getting a teaser solution that I’ve been inspired to write about today, plus a few updates on my Real Money Portfolio stocks. First, those (pretty minor) updates… One of the worst-performing stocks I own over the past year or […]
Things will be a little quiet here at Stock Gumshoe for the next week or so — I’m off to do my big fundraising ride for Dana-Farber tomorrow, and will then be taking several days off to recuperate next week and spend time with family… I’ll be back with the Friday File next week, but […]
This week I’m breaking up the Friday File into two parts — there was a clamor of request to cover the latest “Code of Life” teaser pitch from Michael Robinson, so I did that for you in a separate piece today… And I’ve also got some comments about recent earnings updates and some other news […]
Motley Fool Canada launched a new dividend-focused newsletter service called Dividend Investor Canada earlier this year, and they’re now promoting it using a promise that they’re finding retail’s “next generation of ‘hidden millionaires.” And, of course, the bait that they dangle to entice you to subscribe is a report with some “secret” stocks that they […]
For those who’ve been paying attention, we finally got the expected official Dataram/US Gold name/ticker change…. it’s now U.S. Gold Corp, an the ticker is now USAU. The stock is not moving at the moment, which makes sense — I’d guess that the highest probability near-term news is a secondary offering, which would be negative… […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can find his bio and his past articles on his Stock Gumshoe page.] “The universe (which others call the Library) is composed of an indefinite and […]
I’ve got a soft spot in my heart (or maybe my head, depends who you ask) for the Motley Fool’s old “Superbrand” ads — one of the very first teaser pitches I covered when I started this website in the Spring of 2007 was the Gardner brothers’ teaser for the “New American Superbrand”. That ad […]
Alternative Health, Supplements and RelatedOver time, I will try to collect past posts on these topics and collect them here. I’ll try to get the original posters and dates, although some are missing in this first post. JIN SHIN JYUTSU POSTS BY REBS (formerly Roger) Roger – At 87 I do Qigong, 8 brocades, Yang 10, 24, 48, 42, […]
Louis Navellier is out with another of his “only a few hours left” promos to drum up new subscribes for his Ultimate Growth newsletter — he says he’s seeing huge opportunities in “AAA Rated” China growth stocks… … and in order to convince you to subscribe, he’s dropping some hints to whet your appetite for […]
[ed. note: Michael Jorrin, who I call Doc Gumshoe, is a longtime medical writer (not a doctor) who writes for us about medicine and health a couple times a month. He has agreed to our trading and disclosure restrictions, but does not generally write directly about investment ideas. His ideas, thoughts and words are his […]
Lots of folks have been asking me about Bitcoin and Ethereum and the other alt-currencies of late, for obvious reasons (well, it’s obvious why folks are curious about it — far less obvious why anyone would seek my wisdom on the subject)… so I’ve got an extended bit of blather about those currencies to share […]
First, let’s get the week’s changes to my Real Money Portfolio out of the way… and after that, I’ve got a few other updates on stocks that I follow for you, dear Irregulars. We’ve got a new stock in the portfolio…. As of tomorrow, I will have a position in NVIDIA (NVDA). This is a […]
Note: the first version of this article contained some errors in price and calculation in the examples given, now corrected. I wrote some about Michael Lewitt’s Zenith Trading Circle when it was launched last September, and there have been several discussion threads about it over the past six months as well. From what I hear, […]
In how many areas of life can you be guaranteed to get average results even if your abilities are inferior? That was one of my favorites quotes from the presentation by Ed Wachenheim at the Grant’s Conference: “People with inferior abilities can get average results with an index fund, which is remarkable.” But, of course, […]
Anybody else see this? Aurico is currently trading for $2.86/share. Just curious as to the thoughts of others — seems like there is an arbitrage opportunity, depending on the certainty of close. http://www.kiskametals.com/s/News.asp?ReportID=781835 NEWS RELEASES Mar 08, 2017 AURICO METALS INC. COMPLETES ACQUISITION OF KISKA METALS CORPORATION Vancouver, B.C., March 8, 2017 — Kiska Metals […]
Paul Mampilly is out with a new promo for his Extreme Fortunes newsletter, making this absurd promise: “Anyone who joins my research service Extreme Fortunes, and invests $10,000 following my recommendations, will have the chance to earn a profit of $100,000… in the next year.” So before we begin, let’s throw away that possibility. You’re […]
This is from Irregular Lee Salisbury: I subscribe to Mampilly’s Profit Unlimited which recommends the likes of IBM, MSFT, QRVO, STM, TER, ADSK, PYPL, etc., etc. Because I’ve found Mampilly’s service reputable I listened to his newest pitch costing a mere $2995/yr, no trials, all sales final. I didn’t buy it but have to say […]